PL2529735T3 - Kompozycje zawierające pochodne 4-(heterocykloalkilo)benzeno-1,3-diolu o działaniu hamującym enzym tyrozynazę - Google Patents

Kompozycje zawierające pochodne 4-(heterocykloalkilo)benzeno-1,3-diolu o działaniu hamującym enzym tyrozynazę

Info

Publication number
PL2529735T3
PL2529735T3 PL12182351T PL12182351T PL2529735T3 PL 2529735 T3 PL2529735 T3 PL 2529735T3 PL 12182351 T PL12182351 T PL 12182351T PL 12182351 T PL12182351 T PL 12182351T PL 2529735 T3 PL2529735 T3 PL 2529735T3
Authority
PL
Poland
Prior art keywords
heterocycloalkyl
benzene
compositions
inhibiting activity
enzyme inhibiting
Prior art date
Application number
PL12182351T
Other languages
English (en)
Inventor
Jean-Guy Boiteau
Jean-Claude Pascal
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of PL2529735T3 publication Critical patent/PL2529735T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12182351T 2008-12-02 2009-12-02 Kompozycje zawierające pochodne 4-(heterocykloalkilo)benzeno-1,3-diolu o działaniu hamującym enzym tyrozynazę PL2529735T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0858206A FR2939136B1 (fr) 2008-12-02 2008-12-02 Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
US20212809P 2009-01-30 2009-01-30
EP12182351.2A EP2529735B1 (en) 2008-12-02 2009-12-02 Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity
EP09796990A EP2373310B1 (en) 2008-12-02 2009-12-02 Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics

Publications (1)

Publication Number Publication Date
PL2529735T3 true PL2529735T3 (pl) 2015-01-30

Family

ID=40845880

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09796990T PL2373310T3 (pl) 2008-12-02 2009-12-02 Nowe związki 4-(heterocykloalkilo)benzeno-1,3-diolu jako inhibitory tyrozynazy, sposób ich otrzymywania oraz zastosowanie w medycynie i w kosmetykach
PL12182351T PL2529735T3 (pl) 2008-12-02 2009-12-02 Kompozycje zawierające pochodne 4-(heterocykloalkilo)benzeno-1,3-diolu o działaniu hamującym enzym tyrozynazę

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09796990T PL2373310T3 (pl) 2008-12-02 2009-12-02 Nowe związki 4-(heterocykloalkilo)benzeno-1,3-diolu jako inhibitory tyrozynazy, sposób ich otrzymywania oraz zastosowanie w medycynie i w kosmetykach

Country Status (20)

Country Link
US (1) US8372879B2 (pl)
EP (2) EP2373310B1 (pl)
JP (1) JP5395188B2 (pl)
KR (1) KR101290504B1 (pl)
CN (1) CN102238948B (pl)
AR (1) AR074454A1 (pl)
AU (1) AU2009324080B2 (pl)
BR (1) BRPI0916504B8 (pl)
CA (1) CA2742703C (pl)
DK (1) DK2373310T3 (pl)
ES (2) ES2506265T3 (pl)
FR (1) FR2939136B1 (pl)
HR (1) HRP20120954T1 (pl)
MX (1) MX2011005479A (pl)
PL (2) PL2373310T3 (pl)
PT (1) PT2373310E (pl)
RU (1) RU2482116C2 (pl)
SI (1) SI2373310T1 (pl)
SM (1) SMT201200057B (pl)
WO (1) WO2010063773A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
ME02754B (me) * 2011-03-23 2018-01-20 Trevena Inc Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
WO2014125231A1 (fr) 2013-02-14 2014-08-21 Galderma Research & Development Procede de synthese de composes 4-(heterocycloalkyl)-benzene-1,3-diol
WO2014139080A1 (en) * 2013-03-12 2014-09-18 Boehringer Ingelheim International Trading (Shanghai) Co., Ltd. Novel process for the manufacture of 3-oxo-tetrahydrofuran
FR3030251B1 (fr) * 2014-12-22 2018-11-02 L'oreal Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier
FR3030250B1 (fr) * 2014-12-22 2018-11-02 L'oreal Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un hydrotrope
FR3030249B1 (fr) * 2014-12-22 2018-11-02 L'oreal Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol, un polymere et un glycol
FR3030252B1 (fr) * 2014-12-22 2018-11-02 L'oreal Composition aqueuse comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol, un monoalcool en c2-c4 et un glycol
JP6873598B2 (ja) * 2015-12-22 2021-05-19 ロレアル 活性成分のための改善された局所送達系

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651619B2 (ja) 1988-05-09 1994-07-06 株式会社クラレ 美白剤
FR2704428B1 (fr) 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
US6068834A (en) * 1994-03-04 2000-05-30 The Procter & Gamble Company Skin lightening compositions
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
JPH11255637A (ja) * 1998-03-13 1999-09-21 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
JP2004508343A (ja) * 2000-09-07 2004-03-18 ウイスコンシン　アラムニ　リサーチ　ファンデーション １７ｆ標識フルオロアルカンの合成
CA2421880C (en) * 2000-09-11 2008-03-11 Pfizer Products Inc. Resorcinol derivatives
US6852310B2 (en) 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
US7300646B2 (en) 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20060210497A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Also Published As

Publication number Publication date
BRPI0916504A2 (pt) 2015-11-10
EP2373310A1 (en) 2011-10-12
RU2482116C2 (ru) 2013-05-20
PT2373310E (pt) 2012-12-06
PL2373310T3 (pl) 2013-02-28
CA2742703A1 (en) 2010-06-10
BRPI0916504B1 (pt) 2018-12-18
US8372879B2 (en) 2013-02-12
MX2011005479A (es) 2011-06-20
BRPI0916504B8 (pt) 2019-04-02
HRP20120954T1 (hr) 2012-12-31
JP2012510452A (ja) 2012-05-10
ES2506265T3 (es) 2014-10-13
FR2939136A1 (fr) 2010-06-04
AR074454A1 (es) 2011-01-19
SMT201200057B (it) 2013-01-14
AU2009324080B2 (en) 2012-10-04
FR2939136B1 (fr) 2010-12-03
SI2373310T1 (sl) 2013-01-31
CN102238948B (zh) 2015-03-25
DK2373310T3 (da) 2012-12-17
JP5395188B2 (ja) 2014-01-22
KR101290504B1 (ko) 2013-07-29
KR20110091583A (ko) 2011-08-11
AU2009324080A1 (en) 2010-06-10
EP2373310B1 (en) 2012-10-10
RU2011127120A (ru) 2013-01-20
EP2529735B1 (en) 2014-06-25
WO2010063773A1 (en) 2010-06-10
CA2742703C (en) 2014-04-08
EP2529735A1 (en) 2012-12-05
CN102238948A (zh) 2011-11-09
US20120041213A1 (en) 2012-02-16
ES2393916T3 (es) 2013-01-02

Similar Documents

Publication Publication Date Title
LTPA2018510I1 (lt) Dioksa-biciklo[3.2.1]oktan-2,3,4-triolio dariniai
LTPA2017039I1 (lt) Pirolopirimidino junginiai, kaip CDK inhibitoriai
BRPI0906973A2 (pt) Compostos e composições como inibidores de cinase.
PL2271660T3 (pl) Stabilizowane ciekłe kompozycje enzymów
IL210195A0 (en) Benzoxazines, benzothazines, and related compounds having nos inhibitory activity
LT2280687T (lt) Kramtomosios gumos kompozicijos, apimančios kanabinoidus
AP2010005380A0 (en) Extracellular matrix compositions.
EP2513022A4 (en) AZEOTROPENEAN COMPOSITIONS OF CIS-1,1,1,4,4,4-HEXAFLUOR-2-BUTENE
SI2321235T1 (sl) Uporaba sestavka za pospeševanje strjevanja, ki vsebuje mehčalec
BRPI1010301A2 (pt) composição.
AP2010005465A0 (en) Pesticidal compositions.
EP2421368A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR PYRIDAZINE SULFONAMIDE DERIVATIVES
BRPI0907584A2 (pt) Composto e composições como moduladores de atividade de gpr119
ECSP12011946A (es) Derivados de dioxa- biciclo [3.2.1] octano- 2 ,3,4- triol
NL1036050C (nl) Brandvertragende en brandwerende samenstelling.
DK3196302T3 (da) Små enzymholdige granuler
BRPI0918637A2 (pt) composição antimicrobiana.
BRPI0917982A2 (pt) composição de alvejamento particulada que compreende enzimas
BRPI0917172A2 (pt) Composição bacteriana
ZA201102443B (en) Dishwashing composition
EP2091530A4 (en) Composition for inhibiting nadph oxidase activity
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
IT1393413B1 (it) Composizione pesticida.
BRPI1009264A2 (pt) composição adesiva melhorada.
BRPI0919803A2 (pt) composições agrícolas